Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The Hair660™ light therapy device effectively and safely improves hair density in people with androgenetic alopecia.

Danthron from Rhubarb causes melanoma cells to stop growing and die.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Reflectance confocal microscopy reliably identifies skin cancer features like horizontal skin tissue sections.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

A new form of lipodystrophy in HIV patients causes neck fat buildup.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Belatacept may be a promising treatment for alopecia areata.

ILC1 cells contribute to hair loss in alopecia areata.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

SOX4 is crucial for the development of melanoma.

CD34 is crucial for skin tumor development in mice.

Chemotherapy reduces splenic melanin in mice.

Young donor, early passage stem cells have the highest stemness.

miR-486 may help prevent hair loss in alopecia areata.

Rituximab may cause skin issues, but baricitinib can help improve them.

308 nm excimer lamp therapy is effective for alopecia areata but less so for severe cases.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

SHISA6 helps maintain certain stem cells in mouse testes by blocking signals that would otherwise cause them to differentiate.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.